Involvement of Hemopexin in the Pathogenesis of Proteinuria in Children with Idiopathic Nephrotic Syndrome

被引:11
作者
Pukajlo-Marczyk, Agnieszka [1 ]
Zwolinska, Danuta [1 ]
机构
[1] Wroclaw Med Univ, Dept Pediat Nephrol, Borowska 213, PL-50556 Wroclaw, Poland
关键词
hemopexin; nephrotic syndrome; children; MINIMAL CHANGE DISEASE; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ACUTE-PHASE PROTEINS; GLOMERULAR-PERMEABILITY; PLASMA HEMOPEXIN; INTERLEUKIN-8; NEPHROPATHY; LEVEL; IL-13; SUPAR;
D O I
10.3390/jcm10143160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemopexin (Hpx) is considered a factor in the pathogenesis of idiopathic nephrotic syndrome (INS). The aim of the study was to evaluate the serum and urine values of Hpx (sHpx and uHpx) in children with INS, analyze the role of Hpx, and assess its usefulness as a marker of the disease course. 51 children with INS and 18 age-matched controls were examined. Patients were divided into subgroups depending on the number of relapses (group IA-the first episode of INS, group IB-with relapses) and according to method of treatment (group IIA treated with gluco-corticosteroids (GCS), group IIB treated with GCS and other immunosuppressants). Hpx concentrations were determined by enzyme-linked immunosorbent assay (ELISA). sHpx and uHpx values in relapse were elevated in the whole INS group versus controls (p < 0.000). In remission their levels decreased, but still remained higher than in the control group (p < 0.000). In group IB uHpx levels were increased during remission as compared to group IA (p < 0.006). No significant impact of immuno-suppressants on sHpx was observed, but uHpx excretion in group IIA was higher in relapse (p < 0.026) and lower in remission (p < 0.0017) as compared to group IIB. The results suggest the role of Hpx in the pathogenesis of INS. Hpx may be a useful indicator for continuation of treatment, but it requires confirmation by further controlled studies.
引用
收藏
页数:11
相关论文
共 54 条
[1]   STRUCTURE OF THE HUMAN HEMOPEXIN GENE AND EVIDENCE FOR INTRON-MEDIATED EVOLUTION [J].
ALTRUDA, F ;
POLI, V ;
RESTAGNO, G ;
SILENGO, L .
JOURNAL OF MOLECULAR EVOLUTION, 1988, 27 (02) :102-108
[2]  
[Anonymous], 1981, KIDNEY INT, V20, P765
[3]  
[Anonymous], KDIGO CLIN PRACTICE
[4]  
[Anonymous], Nephrotic syndrome in children
[5]   Altered activity of plasma hemopexin in patients with minimal change disease in relapse [J].
Bakker, WW ;
van Dael, CML ;
Pierik, LJWM ;
van Wijk, JAE ;
Nauta, J ;
Borghuis, T ;
Kapojos, JJ .
PEDIATRIC NEPHROLOGY, 2005, 20 (10) :1410-1415
[6]   Protease activity of plasma hemopexin [J].
Bakker, WW ;
Borghuis, T ;
Harmsen, MC ;
van den Berg, A ;
Kema, IP ;
Niezen, KE ;
Kapojos, JJ .
KIDNEY INTERNATIONAL, 2005, 68 (02) :603-610
[7]   URINARY PROTEINS AND RED-BLOOD-CELL MEMBRANE NEGATIVE CHARGES IN DIABETES-MELLITUS [J].
BERNARD, A ;
AMOR, AO ;
GOEMAREVANNESTE, J ;
ANTOINE, JL ;
LAUWERYS, R ;
COLIN, I ;
VANDELEENE, B ;
LAMBERT, A .
CLINICA CHIMICA ACTA, 1990, 190 (03) :249-262
[8]   Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis? [J].
Cara-Fuentes, Gabriel ;
Wasserfall, Clive H. ;
Wang, Heiman ;
Johnson, Richard J. ;
Garin, Eduardo H. .
PEDIATRIC NEPHROLOGY, 2014, 29 (12) :2333-2340
[9]   CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance [J].
Cara-Fuentes, Gabriel ;
Wei, Changli ;
Segarra, Alfons ;
Ishimoto, Takuji ;
Rivard, Christopher ;
Johnson, Richard J. ;
Reiser, Jochen ;
Garin, Eduardo H. .
PEDIATRIC NEPHROLOGY, 2014, 29 (08) :1363-1371
[10]   Hemopexin is up-regulated in plasma from type 1 diabetes mellitus patients: Role of glucose-induced ROS [J].
Chen, Chia-Ching ;
Lu, Ying-Chieh ;
Chen, Yi-Wen ;
Lee, Wen-Li ;
Lu, Chieh-Hsiang ;
Chen, You-Hsuan ;
Lee, Yun-Ching ;
Lin, Szu-Ting ;
Timms, John F. ;
Lee, Ying-Ray ;
Chou, Hsiu-Chuan ;
Chan, Hong-Lin .
JOURNAL OF PROTEOMICS, 2012, 75 (12) :3760-3777